Pleural diseases encompass a wide range of conditions affecting the pleura, the thin membrane surrounding the lungs and lining the chest cavity. These conditions include pleural effusion, pneumothorax, pleuritis, empyema, and pleural tumors. Patients may present with chest discomfort, shortness of breath, cough, or asymptomatic findings detected incidentally on imaging. Accurate pleural disease diagnosis is essential to identify the underlying cause, guide treatment, and prevent complications such as lung collapse, infection, or fibrosis. Clinical assessment begins with a thorough history and physical examination, evaluating risk factors such as recent infections, trauma, malignancy, or systemic illnesses. Imaging modalities, including chest X-rays, ultrasound, and high-resolution CT scans, provide critical information on fluid accumulation, pleural thickening, or air collections.
Definitive diagnosis often requires targeted sampling of pleural fluid or tissue. Thoracentesis allows analysis of pleural fluid for cell count, chemistry, microbiology, and cytology, helping differentiate between transudative and exudative processes. In some cases, pleural biopsy or video-assisted thoracoscopic surgery may be needed to detect malignancy or chronic inflammatory conditions. Ongoing monitoring through imaging and laboratory studies is crucial to track disease progression and assess response to therapy. Multidisciplinary involvement—including pulmonologists, radiologists, and thoracic surgeons—ensures comprehensive evaluation, individualized treatment planning, and timely intervention. By combining careful clinical assessment, advanced imaging, and procedural diagnostics, pleural disease diagnosis can accurately identify underlying causes, optimize patient outcomes, and reduce long-term respiratory complications.
Title : Novel signaling mechanisms and innovative therapeutic strategies of pulmonary hypertension
Yong Xiao Wang, Albany Medical College, United States
Title : Changing population immunity to COVID-19 in the context of infection, vaccination and emerging SARS-CoV-2 variants
Ranjan Ramasamy, ID-FISH Technology, United States
Title : Susceptibility to SARS-CoV-2 infection and nasal air conditioning ability
Ranjan Ramasamy, ID-FISH Technology, United States
Title : Comparative evaluation of DECAF and BAP 65 scores in predicting outcomes of COPD exacerbations among in patients at Vicente Sotto Memorial Medical Center
Allanys Joy Q Pino, Vicente Sotto Memorial Medical Center, Philippines
Title :
Saurabh Chattopadhyay, University of Kentucky College of Medicine, United States
Title : Personalized and precision Medicine (PPM) as a unique healthcare model through biodesign driven and inspired biotech, translational applications and pulmonology related marketing to secure the human healthcare, wellness and biosafety
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation